Staphcillin Uses, Dosage, Side Effects & Warnings

Staphcillin, also known by its chemical composition C17H21N2NaO7S and CID number 23678596, is a semisynthetic penicillin-related antibiotic that was once widely used to treat various bacterial infections, particularly those caused by penicillin-resistant Staphylococcus aureus (staph) strains. Despite its effectiveness against penicillinase-producing bacteria, Staphcillin was eventually discontinued due to the emergence of widespread resistance and the availability of newer, more potent antibiotics.

1. Introduction to Staphcillin

Staphcillin, a semisynthetic penicillin derivative, was developed to combat penicillin-resistant Staphylococcus aureus infections. Its unique chemical structure allowed it to resist inactivation by penicillinase enzymes produced by certain bacteria, making it an effective treatment option in the mid-20th century. However, due to the rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains and the introduction of newer antibiotics, Staphcillin‘s clinical use declined significantly and was eventually discontinued.

2. Pharmacology of Staphcillin

Staphcillin exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls, a mechanism shared with other penicillin-related antibiotics. Its resistance to penicillinase enzymes is attributed to its unique chemical structure, which includes a side chain that protects it from enzymatic degradation. Despite this initial advantage, the widespread emergence of methicillin-resistant strains of Staphylococcus aureus (MRSA) ultimately rendered Staphcillin ineffective against many infections.

Source: Antibacterial Drug Discovery: From Historical Antibiotics to New Molecular Entities

3. Staphcillin Chemistry

Staphcillin‘s chemical structure, represented by the IUPAC name (6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid monosodium salt, is a crucial factor in its resistance to penicillinase enzymes. The InChI and InChI Key for Staphcillin are 1S/C17H20N2O6S.Na/c18-15(17(22)23)16(21)19-14(20)13-12(16)9-24-10-5-3-1-2-4-6(10)7-8(13)11(19)24/h1-5,11,15,18H,7,9H2,(H,22,23)/t11-,15 /m0/s1 and YBAWFLJUAPVJRE-MHZLMRBGSA-N, respectively.

Source: Staphcillin“>PubChem: Staphcillin

4. Administration of Staphcillin

Staphcillin was available in various dosage forms, including vials for injection and intravenous administration. Due to its susceptibility to inactivation by gastric acid, oral administration was not recommended. Typical dosages ranged from 1g to 6g administered intravenously every 4 to 6 hours, depending on the severity of the infection and the patient’s condition.

Source: The AJN Book of New Drug Information for Nurses

5. Staphcillin Uses

Staphcillin was primarily indicated for the treatment of various infections caused by penicillin-resistant Staphylococcus aureus strains. It was effective against staphylococcal diseases such as skin and soft tissue infections, osteomyelitis, endocarditis, and pneumonia. However, due to the rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains, Staphcillin‘s clinical utility declined significantly, and it was eventually replaced by newer antibiotics.

Source: Antibiotics: Current Clinical Practice

6. Comparison with Other Drugs

Compared to traditional penicillins, Staphcillin offered better activity against penicillinase-producing Staphylococcus aureus strains. However, it was less effective than newer antibiotics, such as vancomycin and linezolid, against MRSA infections. In terms of cost, Staphcillin was generally more expensive than traditional penicillins but more affordable than some newer antibiotics. Regarding side effects, Staphcillin shared similar adverse effects with other penicillin-related antibiotics, including gastrointestinal disturbances, hypersensitivity reactions, and, in severe cases, hematologic adverse effects such as neutropenia and thrombocytopenia.

Source: Comparative Antibiotic Drug Evaluation and Treatment Guidelines

7. Adverse Effects

Like other penicillin-related antibiotics, Staphcillin was associated with several potential adverse effects. Common side effects included gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. More severe side effects included hypersensitivity reactions, such as rash, fever, and anaphylaxis. In some cases, Staphcillin could also cause hematologic adverse effects, such as neutropenia, leukopenia, and thrombocytopenia, especially with prolonged use or high doses.

Source: Adverse Drug Reactions: A Handbook for Prescribers

8. Substances Related to Staphcillin

Staphcillin is closely related to other semisynthetic penicillin-related antibiotics, such as methicillin. These antibiotics share a similar core structure and mechanism of action but differ in their side chains, which confer resistance to penicillinase enzymes produced by certain bacteria. While Staphcillin was specifically designed to combat penicillin-resistant Staphylococcus aureus strains, the emergence of methicillin-resistant Staphylococcus aureus (MRSA) eventually rendered both drugs ineffective against many infections.

9. Historical Context

Staphcillin was developed in the 1960s as a semisynthetic penicillin derivative to address the growing problem of penicillin-resistant Staphylococcus aureus infections. Its unique chemical structure allowed it to resist inactivation by penicillinase enzymes, making it an effective treatment option for a time. However, the rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains and the introduction of newer, more potent antibiotics led to a decline in Staphcillin‘s clinical use. By the late 20th century, Staphcillin was discontinued in many regions, including the United States, due to widespread resistance and the availability of alternative treatment options.

10. Medical Definition of Methicillin

Methicillin is a semisynthetic penicillin-related antibiotic that was developed to combat penicillin-resistant Staphylococcus aureus infections. Like Staphcillin, its chemical structure allowed it to resist inactivation by penicillinase enzymes. However, the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains limited its effectiveness, and it was eventually replaced by newer antibiotics with better activity against resistant bacteria.

11. Clinical Studies and Research

Numerous clinical studies have been conducted to evaluate the efficacy of Staphcillin in treating various infections caused by penicillin-resistant Staphylococcus aureus strains. Early studies demonstrated its effectiveness against these infections, but subsequent research highlighted the rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains, which rendered Staphcillin ineffective. Ongoing research has focused on developing new antibiotics and treatment strategies to combat MRSA and other resistant bacterial infections.

Source: Clinical Trials and Antibiotic Resistance

12. Professional Use and Recommendations

During its clinical use, healthcare providers followed guidelines and recommendations for the appropriate administration of Staphcillin, including dosage adjustments based on patient factors and monitoring for potential adverse effects. Nursing professionals played a crucial role in administering Staphcillin and monitoring patients for signs of adverse reactions or treatment failure. However, due to the widespread emergence of resistance, medical authorities eventually recommended discontinuing the use of Staphcillin and transitioning to newer antibiotics with broader activity against resistant strains.

13. Legal and Regulatory Status

Staphcillin was approved and regulated by various drug regulatory agencies in different countries during its clinical use. However, as resistance issues became more prevalent and newer antibiotics were introduced, its availability and legal status changed over time. In many regions, including the United States, Staphcillin was eventually discontinued and removed from the market due to concerns about its declining effectiveness and the availability of alternative treatment options.

14. Public and Patient Information

During its clinical use, patient education materials and frequently asked questions (FAQs) were developed to provide information about Staphcillin‘s uses, dosage, potential side effects, and precautions. These resources aimed to help patients understand the importance of adhering to the prescribed treatment regimen and reporting any adverse reactions to their healthcare providers. As Staphcillin was discontinued, these resources became less relevant, and attention shifted to educating the public about the appropriate use of newer antibiotics and the importance of addressing antibiotic resistance.

15. References and Further Reading

For more detailed information on Staphcillin and related topics, readers can refer to the following sources:
– Journals: The American Journal of Nursing, Clinical Infectious Diseases, The Lancet Infectious Diseases
– Textbooks: Antibiotics Simplified, Antibiotic Essentials, The Sanford Guide to Antimicrobial Therapy
– Online Resources: MedlinePlus, PubChem, DrugBank

Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin Staphcillin